Staying Competitive and Compliant in the EU: 2013 Key Developments on Competition Matters
30 January 2014
Foley attorneys Howard W. Fogt and Sophie Lignier will be discussing the latest trends and developments in the EU’s competition law, including:
- Cartel: cartel enforcement and leniency in the EU; dawn raids procedure; agreements of minor importance
- Unilateral conduct: non-compliance with commitments decision; interplay between IP and competition law; standard essential patents (SEPs)
- Merger: simplifying merger procedures further; issue of minority shareholding; the interplay between EU and national merger control
- Distribution: RPM, MAP, and restrictions by object
- Private enforcement and implication for leniency applicants; impact of recent case law
There is no cost to participate in this program, but advance registration is required. To participate, please register here. Instructions for accessing the program will be included in the registration confirmation email.
Should you have additional questions, please contact Katie Egan at [email protected].
People
Related Insights
21 October 2024
Events
Legal Overview of the BIOSECURE Act
Foley special counsel John Strom is speaking in the Association for Accessible Medicine’s GRx+Biosims 2024 conference in a panel titled “Legal Overview of the BIOSECURE Act” on October 21.
04 October 2024
Innovative Technology Insights
Decoding California’s Recent Flurry of AI Laws
Governor Newsom signed over 18 AI-related bills into law during September, impacting numerous industries.
17 October 2024
Events
Top Compliance Considerations when Commercializing in the U.S.
Kyle Faget and Nathan "Nate" Beaver, co-chair of Foley's Medical Device and Equipment Area of Focus within the firm's Health Care & Life Sciences Sector, invite you to join us for a webinar on the compliance considerations you need to know when you are commercializing your medical device products in the U.S.